/u/WalkingHorse's posts

Year:

Only show posts with narrations

Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Real-World Pharmacokinetics, Effectiveness, and Safety of Atezolizumab in Patients With Unresectable Advanced or Recurrent NSCLC: An Exploratory Study of J-TAIL

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

The influence of nutritional status, lipid profile, leptin concentration and polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of immunotherapy in advanced NSCLC patients | BMC Cancer

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Inhibition of DDR1 promotes ferroptosis and overcomes gefitinib resistance in non-small cell lung cancer

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

In silico analysis of DEL-1 and inflammation-related genes in lung squamous cell carcinoma

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Metastatic Non–Small-Cell Lung Cancer Presenting as Renal Failure From IgA Nephropathy

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

CT-based deep learning radiomics biomarker for programmed cell death ligand 1 expression in non-small cell lung cancer | BMC Medical Imaging

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Exosomal miR-106a-5p derived from intermittently hypoxic non-small-cell lung cancer increases tumor malignancy.

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

First Patient with SCLC Dosed With I-DXd in Phase 3 Study

1 upvotes • r/LungCancerSupport

Mark as read: Add to a list

Title	Upvotes	Subreddit	Mark as read	Favorited	Rating	Add to a list
Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer	1	LungCancerSupport
Real-World Pharmacokinetics, Effectiveness, and Safety of Atezolizumab in Patients With Unresectable Advanced or Recurrent NSCLC: An Exploratory Study of J-TAIL	1	LungCancerSupport
The influence of nutritional status, lipid profile, leptin concentration and polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of immunotherapy in advanced NSCLC patients \| BMC Cancer	1	LungCancerSupport
Inhibition of DDR1 promotes ferroptosis and overcomes gefitinib resistance in non-small cell lung cancer	1	LungCancerSupport
In silico analysis of DEL-1 and inflammation-related genes in lung squamous cell carcinoma	1	LungCancerSupport
High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse	1	LungCancerSupport
Metastatic Non–Small-Cell Lung Cancer Presenting as Renal Failure From IgA Nephropathy	1	LungCancerSupport
CT-based deep learning radiomics biomarker for programmed cell death ligand 1 expression in non-small cell lung cancer \| BMC Medical Imaging	1	LungCancerSupport
Exosomal miR-106a-5p derived from intermittently hypoxic non-small-cell lung cancer increases tumor malignancy.	1	LungCancerSupport
First Patient with SCLC Dosed With I-DXd in Phase 3 Study	1	LungCancerSupport